Study Links High-Dose Flu Vaccines to Lower Alzheimer’s Risk
A study led by UTHealth Houston researchers has linked high-dose influenza vaccination to a lower risk of Alzheimer’s disease among adults aged 65 and older. The findings, published in Neurology, suggest an association between vaccine dosage and subsequent diagnoses but do not establish that vaccination prevents the disease.
The team analyzed data from nearly 200,000 older adults who received either high-dose or standard-dose flu vaccines. Researchers reported that standard-dose vaccination was associated with a 40% reduction in Alzheimer’s risk, while high-dose vaccination was linked to a reduction of nearly 55%. The association was more pronounced among women.
The investigation followed earlier research led by neurologist Paul Schulz that connected flu vaccination with reduced Alzheimer’s risk. Discussions with local public health officials prompted the team to examine whether different vaccine doses were associated with different outcomes. Variation in which formulations older adults received provided an opportunity for comparison.
High-dose flu vaccines contain four times as much influenza antigen as standard-dose versions. They are designed to produce a stronger immune response in older adults, whose immune systems generally become less effective with age. The CDC identifies high-dose influenza vaccination as a preferred option for people who are 65 and older.
Alzheimer’s is the leading cause of dementia. According to figures cited in the report, more than seven million Americans aged 65 and older were living with the disease in 2025. That number is projected to more than double by 2050, underscoring the importance of research into potential risk reduction.
Further research is needed to determine whether vaccination directly affects Alzheimer’s risk and to investigate possible biological mechanisms. The findings raise questions about how immune responses may relate to brain health, but they do not establish high-dose flu vaccination as an Alzheimer’s prevention strategy. The reported differences require additional investigation and confirmation.